These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 11829949)

  • 1. [Detection of telomerase activity in prostate needle-biopsy samples].
    Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of telomerase activity in prostate cancer by needle biopsy.
    Takahashi C; Miyagawa I; Kumano S; Oshimura M
    Eur Urol; 1997; 32(4):494-8. PubMed ID: 9412813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
    Zhang W; Kapusta LR; Slingerland JM; Klotz LH
    Cancer Res; 1998 Feb; 58(4):619-21. PubMed ID: 9485010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in primary prostate cancer.
    Lin Y; Uemura H; Fujinami K; Hosaka M; Harada M; Kubota Y
    J Urol; 1997 Mar; 157(3):1161-5. PubMed ID: 9072562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
    Botchkina GI; Kim RH; Botchkina IL; Kirshenbaum A; Frischer Z; Adler HL
    Clin Cancer Res; 2005 May; 11(9):3243-9. PubMed ID: 15867219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer.
    Allen D; Butt A; Cahill D; Wheeler M; Popert R; Swaminathan R
    Ann N Y Acad Sci; 2004 Jun; 1022():76-80. PubMed ID: 15251943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
    Koeneman KS; Pan CX; Jin JK; Pyle JM; Flanigan RC; Shankey TV; Diaz MO
    J Urol; 1998 Oct; 160(4):1533-9. PubMed ID: 9751408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer.
    Glybochko PV; Zezerov EG; Glukhov AI; Alyaev YG; Severin SE; Polyakovsky KA; Varshavsky VA; Severin ES; Vinarov AZ
    Prostate; 2014 Jul; 74(10):1043-51. PubMed ID: 24854433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
    Goel T; Garg S
    Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
    Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
    J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
    Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
    Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity: a prevalent marker of malignant human prostate tissue.
    Sommerfeld HJ; Meeker AK; Piatyszek MA; Bova GS; Shay JW; Coffey DS
    Cancer Res; 1996 Jan; 56(1):218-22. PubMed ID: 8548767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
    Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P
    J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
    Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
    Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
    Brooks JD; Weinstein M; Lin X; Sun Y; Pin SS; Bova GS; Epstein JI; Isaacs WB; Nelson WG
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):531-6. PubMed ID: 9641498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population.
    Gokden N; Roehl KA; Catalona WJ; Humphrey PA
    Urology; 2005 Mar; 65(3):538-42. PubMed ID: 15780372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
    Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
    Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.